| NCT Number | NCT07743723 |
| Lead Sponsor | Iovance Biotherapeutics, Inc. |
| Conditions | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC), Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Solid Tumors, Unresectable Solid Tumor |
| Enrollment | 106 participants |
| Start Date | 2026-08 |
| Primary Completion | 2034-03 (estimated) |
| Study Completion | 2044-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-06 |